Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Issue 12 (20th July 2021)

Record Type:: Journal Article
Title:: Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Issue 12 (20th July 2021)
Main Title:: Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System
Authors:: Pistor, Maximilian
Hoepner, Andreas G F
Lin, Yanan
Jung, Simon
Bassetti, Claudio L
Chan, Andrew
Salmen, Anke
Hoepner, Robert
Abstract:
Is Part Of:: Annals of the rheumatic diseases. Volume 80:Issue 12(2021)
Journal:: Annals of the rheumatic diseases
Issue:: Volume 80:Issue 12(2021)
Issue Display:: Volume 80, Issue 12 (2021)
Year:: 2021
Volume:: 80
Issue:: 12
Issue Sort Value:: 2021-0080-0012-0000
Page Start:: 1633
Page End:: 1635
Publication Date:: 2021-07-20
Subjects:: COVID-19 -- biological therapy -- autoimmune diseases -- therapeutics
Rheumatism -- Periodicals
616.723005
Journal URLs:: http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗
DOI:: 10.1136/annrheumdis-2021-220679 ↗
Languages:: English
ISSNs:: 0003-4967
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26339.xml